Boston Scientific (BSX) is a publicly traded Healthcare sector company. As of August 16, 2026, BSX trades at $52.32 with a market cap of $75.11B and a P/E ratio of 21.01. BSX moved +1.47% today. Year to date, BSX is -45.64%; over the trailing twelve months it is -50.24%. Its 52-week range spans $42.20 to $109.50. Analyst consensus is strong buy with an average price target of $62.41. Rallies surfaces BSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BSX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $52.32 |
| Market Cap | $75.11B |
| P/E Ratio | 21.01 |
| EPS | $2.49 |
| Dividend Yield | 0.00% |
| 52-Week High | $109.50 |
| 52-Week Low | $42.20 |
| Volume | 14.26M |
| Avg Volume | 0 |
| Revenue (TTM) | $21.00B |
| Net Income | $3.67B |
| Gross Margin | 69.93% |
24 analysts cover BSX: 0 strong buy, 21 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $62.41.